|
Trial no.:
|
PACTR202110569676541 |
Date of Registration:
|
18/10/2021 |
|
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
| TRIAL DESCRIPTION |
|
Public title
|
NORMAL-SALINE VERSUS DEXTROSE-SALINE FOR OXYTOCIN INFUSION DURING INDUCTION OF LABOUR: RANDOMISED CONTROLLED STUDY COMPARING LABOUR DURATION AND FETO-MATERNAL METABOLIC PARAMETERS. |
| Official scientific title |
NORMAL-SALINE VERSUS DEXTROSE-SALINE FOR OXYTOCIN INFUSION DURING INDUCTION OF LABOUR: RANDOMISED CONTROLLED STUDY COMPARING LABOUR DURATION AND FETO-MATERNAL METABOLIC PARAMETERS. |
|
Brief summary describing the background
and objectives of the trial
|
Background
Induction of labour is a common obstetric procedure that has been shown to reduce the rate of caesarean section. Recent research findings have demonstrated that glucose is the major energy substrate for the uterus in labour and there is some evidence that delivery of oxytocin in dextrose saline may confer benefit of shortening the duration of labour. These studies were mainly in non-black population and no such study has been done in UITH Ilorin.
Aim
The aim of this study is to determine the duration of labour in parturient that had oxytocin administration via 5%dextrose in 0.9% normal saline and compare to the duration in those that had it in 0.9% normal saline in UITH Ilorin. The effect of each fluid on maternal and cord blood lactate as well as maternal sodium will also be assessed.
Methods
The study shall be a randomized controlled trial involving pregnant women planned for induction of labour with oxytocin at the department of Obstetrics and Gynaecology University of Ilorin Teaching Hospital, Ilorin. At presentation feto-maternal assessment will be done to rule out contraindications. Vaginal examination will be done and Bishop’s score assigned. Seventy-eight induction of labour packs each containing 3 bags of 500mls intravenous fluids (JUHEL Pharmaceuticals limited) will be used for the study. Thirty nine of the packs will contain normal saline and the other 39 will contain dextrose saline. The fluids in each pack will be stripped of their labels and each pack will be randomly assigned numbers from 1 to 78. Each pack of fluid will then be added to the ‘induction pack’. After patients have been adjudged to have a favourable cervix, they will be assigned the induction packs with the lowest number on its label. Recruitment will follow sequentially until 78 patients are recruited. Sample for maternal baseline lactate and sodium will be obtained just before commencement of oxytocin infusion. Intrapartum fetal monitoring will be done according to departmental protocol noting the duration of first stage of labour, second stage of labour as well as the third stage. Cord blood lactate will also be obtained as well as maternal post-delivery lactate and sodium after delivery of the baby.
Primary outcome measures will be the duration of labour from commencement of oxytocin to delivery of placenta. The secondary outcomes will be neonatal cord lactate level, maternal plasma lactate difference and maternal plasma sodium difference. The outcome measures will be compared between the study groups using SPSS version 23. Chi square at significant level of 0.05 and confidence level of 95% shall be used to determine significance.
|
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Pregnancy and Childbirth |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Drugs |
| Anticipated trial start date |
15/07/2020 |
| Actual trial start date |
15/09/2020 |
| Anticipated date of last follow up |
10/01/2020 |
| Actual Last follow-up date |
17/06/2021 |
| Anticipated target sample size (number of participants) |
78 |
| Actual target sample size (number of participants) |
78 |
| Recruitment status |
Completed |
| Publication URL |
|
|